Point72 Middle East FZE’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,500
Closed -$756K 210
2023
Q4
$756K Buy
7,500
+5,500
+275% +$546K 0.02% 696
2023
Q3
$174K Sell
2,000
-1,400
-41% -$127K 0.01% 1046
2023
Q2
$322K Buy
+3,400
New +$287K 0.01% 913
2023
Q1
Sell
-3,700
Closed -$284K 1688
2022
Q4
$284K Buy
+3,700
New +$281K 0.01% 912

Other funds holding CAH

Point72 Middle East FZE's CAH Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Cardinal Health (CAH) in Q1 2024, closing a stake of 1,201 shares — an estimated $121K sold.

Point72 Middle East FZE first reported a position in CAH in Q4 2022 and held it in 4 quarters. The position peaked at $10.3M in Q3 2023. 1,058 funds tracked by Wall St. Rank hold CAH as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Cardinal Health position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 1,201 Cardinal Health shares in Q1 2024, an estimated $121K.
  • Point72 Middle East FZE first reported a position in Cardinal Health in Q4 2022 and held it in 4 quarters.
  • Point72 Middle East FZE's Cardinal Health position peaked at $10.3M in Q3 2023.
  • 1,058 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.